dacarbazine has been researched along with Pituitary ACTH Hypersecretion in 8 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (12.50) | 29.6817 |
2010's | 7 (87.50) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Gilis-Januszewska, A; Hubalewska-Dydejczyk, A; Kluczyński, Ł; Pach, D; Pantofliński, J; Sokołowski, G; Sowa-Staszczak, A; Turek-Jabrocka, R; Wilusz, M; Zieliński, G | 1 |
Bruce, JN; Carminucci, AS; Fine, RL; Gulati, AP; Lignelli, A; Remotti, H; Siegelin, M; Wardlaw, SL; Zacharia, BE | 1 |
Bruno, OD; Christiansen, SB; Danilowicz, K; Juárez-Allen, L | 1 |
Curtò, L; Trimarchi, F | 1 |
Denew, P; Kurowska, M; Maksymowicz, M; Malicka, J; Tarach, JS; Zieliński, G | 1 |
Fukuhara, N; Inoshita, N; Ohashi, K; Okuda, C; Oyama, K; Sano, T; Taguchi, M; Takeshita, A; Takeuchi, Y; Yamada, S | 1 |
Del Porto, L; Dobson, M; Maartens, NF | 1 |
Altavilla, G; Cannavò, S; Curtò, L; Ferraù, F; Granata, F; Hofland, LJ; Longo, M; Pitini, V; Torre, ML; Trimarchi, F | 1 |
2 review(s) available for dacarbazine and Pituitary ACTH Hypersecretion
Article | Year |
---|---|
Temozolomide therapy for aggressive pituitary Crooke's cell corticotropinoma causing Cushing's Disease - a case report with literature review.
Topics: ACTH-Secreting Pituitary Adenoma; Adenoma; Antineoplastic Agents, Alkylating; Dacarbazine; Fatal Outcome; Humans; Male; Middle Aged; Pituitary ACTH Hypersecretion; Temozolomide | 2018 |
Temozolomide-induced shrinkage of a pituitary carcinoma causing Cushing's disease--report of a case and literature review.
Topics: Adenoma; Adrenocorticotropic Hormone; Adult; Antineoplastic Agents, Alkylating; Dacarbazine; Humans; Male; Pituitary ACTH Hypersecretion; Pituitary Neoplasms; Temozolomide; Treatment Outcome | 2010 |
6 other study(ies) available for dacarbazine and Pituitary ACTH Hypersecretion
Article | Year |
---|---|
High response rates and prolonged survival in patients with corticotroph pituitary tumors and refractory Cushing disease from capecitabine and temozolomide (CAPTEM): a case series.
Topics: ACTH-Secreting Pituitary Adenoma; Adenoma; Adult; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Dacarbazine; Deoxycytidine; Female; Fluorouracil; Humans; Immunohistochemistry; Male; Middle Aged; Pituitary ACTH Hypersecretion; Temozolomide | 2014 |
Long-lasting complete remission after therapy with temozolomide in two patients with macrocorticotropinoma causing Cushing's disease.
Topics: ACTH-Secreting Pituitary Adenoma; Adenoma; Adult; Antineoplastic Agents, Alkylating; Dacarbazine; Female; Humans; Magnetic Resonance Imaging; Middle Aged; Pituitary ACTH Hypersecretion; Remission Induction; Temozolomide; Treatment Outcome; Tumor Burden | 2015 |
Authors' Reply to "Pituitary Atypical Adenoma or Carcinoma Sensitive to Temozolomide Combined with Radiation Therapy: A Case Report of Early Identification and Management".
Topics: Adenoma; Dacarbazine; Humans; Male; Pituitary ACTH Hypersecretion; Pituitary Neoplasms | 2015 |
Long-term complete remission of Crooke's corticotropinoma after temozolomide treatment.
Topics: ACTH-Secreting Pituitary Adenoma; Adenoma; Dacarbazine; Humans; Male; Middle Aged; Pituitary ACTH Hypersecretion; Temozolomide; Treatment Outcome | 2016 |
High incidence of low O(6)-methylguanine DNA methyltransferase expression in invasive macroadenomas of Cushing's disease.
Topics: Adolescent; Adrenocorticotropic Hormone; Adult; Aged; Antineoplastic Agents, Alkylating; Dacarbazine; Female; Humans; Hydrocortisone; Immunohistochemistry; Liver Neoplasms; Male; Middle Aged; O(6)-Methylguanine-DNA Methyltransferase; Pituitary ACTH Hypersecretion; Pituitary Neoplasms; Temozolomide; Tomography, X-Ray Computed; Young Adult | 2009 |
Comment on "Non-surgical treatment of hormone-secreting pituitary tumors".
Topics: Adenoma; Clinical Trials as Topic; Dacarbazine; Humans; Pituitary ACTH Hypersecretion; Pituitary Neoplasms; Somatostatin; Temozolomide; Treatment Outcome | 2010 |